The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation
Open Access
- 1 May 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 7 (3) , 476-483
- https://doi.org/10.1002/hep.1840070311
Abstract
The acute vanishing bile duct syndrome can be defined as an irreversible, rejection-related condition that affects hepatic allografts within 100 days after orthotopic liver transplantation and whose presence requires retransplantation. We have observed the acute vanishing bile duct syndrome in 5 of 48 consecutive patients (approximately 10%) who underwent orthotopic liver transplantation. In 4 cases, the condition progressed relentlessly within approximately 7 to 11 weeks after orthotopic liver transplantation from mild rejection to severe rejection to acute vanishing bile duct syndrome. A fifth patient had severe rejection in the first week and required retransplantation after 17 days because of thrombotic venoocclusive disease complicating the acute vanishing bile duct syndrome. Clinically, signs of impending acute vanishing bile duct syndrome included abrupt onset of fever and jaundice and marked elevation of serum bilirubin and alkaline phosphatase levels which persisted despite antirejection treatment. Biopsy specimens revealed destructive cholangitis (rejection cholangitis), ductopenia, and, if retransplantation was delayed, presence of noninflammatory, “burnt-out” portal tracts without bile ducts. We recommend to base the diagnosis of acute vanishing bile duct syndrome on documentation of severe ductopenia in at least 20 portal tracts which may require several consecutive needle biopsies. Rejection arteriopathy which was found in 3 of our 5 cases might have been another important diagnostic clue but could not be recognized prior to retransplantation. The pathogenesis of acute vanishing bile duct syndrome is not clear; until the condition had manifested itself, we found no qualitative differences between acute reversible and irreversible rejection. After retransplantation, severe rejection has recurred in the four patients who could be evaluated in this regard; one of these patients already needed a second retransplantation for vanishing bile duct syndrome.This publication has 11 references indexed in Scilit:
- Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitisHepatology, 1986
- Peripheral T-Cell Lymphomas: Histologic, Immunohistologic, and Clinical CharacterizationMayo Clinic Proceedings, 1986
- Adult liver transplantation: An analysis of the early causes of death in 40 consecutive casesHepatology, 1986
- The Boston Center for Liver Transplantation (BCLT)Archives of Surgery, 1986
- Histopathology of Early and Late Human Hepatic Allograft Rejection: Evidence of Progressive Destruction of Interlobular Bile DuctsHepatology, 1985
- BIOPSY-DIRECTED IMMUNOSUPPRESSION FOLLOWING HEPATIC TRANSPLATATION IN MANTransplantation, 1985
- Orthotopic Liver Transplantation: A Pathological Study of 63 Serial Liver Biopsies from 17 Patients with Special Reference to the Diagnostic Features and Natural History of Rejection†Hepatology, 1984
- Hepatic Graft Versus Host Disease: A Study of the Predictive Value of Liver Biopsy in DiagnosisHepatology, 1984
- Evolution of Liver TransplantationHepatology, 1982
- ANTIGENIC SPECIFICITY OF ANTIBODY REACTIVE IN THE ANTIGLOBULIN-AUGMENTED LYMPHOCYTOTOXICITY TESTTransplantation, 1982